Patel, Mitesh
Pilcher, Janine
Hancox, Robert J
Sheahan, Davitt
Pritchard, Alison
Braithwaite, Irene
Shaw, Dominick
Black, Peter
Weatherall, Mark
Beasley, Richard
,
Article History
Received: 22 May 2014
Revised: 4 August 2014
Accepted: 30 August 2014
First Online: 8 January 2015
Competing interests
: The Medical Research Institute of New Zealand (MRINZ) has received research funding from AstraZeneca for the unrelated study ‘Pharmacotherapy for the different phenotypes of airways disease’. RH has received payment for lectures from GlaxoSmithKline and support to attend meetings from Boehringer Ingelheim. RB has been a member of the GlaxoSmithKline (NZ) advisory board, consulted for Cytos Biotechnology and Pharmaxis, received research grants from AstraZeneca, Cephalon, Chiesi, Genentech, GlaxoSmithKline and Novartis, payment for lectures or support to attend meetings from Boehringer Ingelheim, GlaxoSmithKline, Novartis, Nycomed and Otsuka Pharmaceuticals. MP, JP, DaS, AP, IB, DoS and MW have no conflicts of interest.